Delivery systems for enhancing oncolytic adenoviruses efficacy

Area of Science:

• Oncolytic virotherapy
• Cancer biology
• Biotechnology

Background:

• Oncolytic adenoviruses (OAds) selectively target and destroy cancer cells.
• Genetic engineering has improved OAd anti-tumor effects.
• Systemic OAd delivery faces hurdles: poor targeting, healthy tissue tropism, low Ad receptor expression, and pre-existing antibodies.

Purpose of the Study:

• To review adenovirus structure and biology.
• To discuss different types of OAds.
• To evaluate the efficacy of various carriers for OAd systemic administration.

Main Methods:

• Literature review of OAd research.
• Analysis of different carrier systems for OAds.
• Examination of OAd structure, biology, and therapeutic applications.

Main Results:

• OAds offer a promising approach to cancer treatment.
• Various carriers (stem cells, NPs, EVs, hydrogels, MPs) enhance OAd efficacy.
• These carriers improve transfection, longevity, targeting, and immune response.

Conclusions:

• Effective systemic delivery of OAds is crucial for maximizing their therapeutic potential.
• Carrier-mediated delivery systems are key to overcoming OAd administration challenges.
• Further research into optimized carrier strategies will advance oncolytic virotherapy.